| Date | Action | Shares | Price | Value | Owned After |
|---|---|---|---|---|---|
| Jun 22, 2026 | Option exercise(M) | 25K | $10.90 | $273K | 49K |
| Jun 22, 2026 | Option exercise(M) | 15K | $11.90 | $179K | 64K |
| Jun 22, 2026 | Sell(S) | 40K | $30.20 | $1.2M | 25K |
| Jun 22, 2026 | Sell(S) | 300 | $30.73 | $9K | 24K |
| Date | Action | Shares | Price | Value | Owned After |
|---|---|---|---|---|---|
| Jun 22, 2026 | Option exercise(M) | 25K | — | $0 | 43K |
| Jun 22, 2026 | Option exercise(M) | 15K | — | $0 | 35K |
Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-26-281062) within minutes of acceptance. Every field above traces to the original document. Verify it directly:
Connected pages for NewAmsterdam Pharma Co N.V.
The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.